In dogs with azotemic CKD, an increased FGF-23 concentration was associated with an increased risk of premature death alongside other previously identified prognostic markers such as proteinuria, hyperphosphatemia, advanced CKD stage, and body condition score [19]. This evidence concerns the gene FGF23 and hyperphosphatemia.